Skip to main content
CTC BIO, INC. logo

CTC BIO, INC. — Investor Relations & Filings

Ticker · 060590 ISIN · KR7060590007 KO Manufacturing
Open in API
Filings indexed 337 across all filing types
Latest filing 2026-05-12 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 060590

About CTC BIO, INC.

https://www.ctcbio.com/

CTC BIO, INC. is a company specializing in the development, manufacturing, and distribution of products for human and animal health. The company leverages core technologies in microbial fermentation and coating to create its product portfolio. Key business areas include human pharmaceuticals, functional foods, and a comprehensive range of animal health solutions. The animal health division offers veterinary medicines, such as antibiotics and coccidiostats, feed additives, and innovative bacteriophage-based products for disease control. In the human health sector, the company provides various pharmaceuticals and is recognized for its advanced manufacturing of probiotics.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled “분기보고서 (제 31 기) 2026년 01월 01일~2026년 03월 31일,” which translates to a quarterly report covering Q1 of fiscal year 2026. It contains detailed company overview, consolidated subsidiary data, managerial changes, capital changes, financial statement tables, business segment breakdown, and other substantive reporting items. This is not merely an announcement or summary, but the full interim financial report itself. Therefore, it fits the definition of an Interim / Quarterly Report (Code: IR). Q1 2026
2026-05-12 Korean
[기재정정]정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is a detailed report of the annual general shareholders’ meeting (정기주주총회) held on 2026-03-26, presenting the meeting resolutions, voting results (votes cast, approval percentages), election of directors and auditors, and related financial statement approvals. This matches the category for Declaration of Voting Results & Voting Rights Announcements (DVA). It is not merely an announcement that a report is available (RPA/RNS), but contains the full voting statements and outcomes.
2026-03-27 Korean
본점소재지변경
Regulatory Filings Classification · 85% confidence The document is a Korean-language announcement titled “본점소재지변경” (head office location change). It lists the previous and new addresses, reason for change, planned move date, and board resolution date. This is not a financial report (10-K, IR), not an earnings release or capital change notice (no share issuance or dividend), nor investor presentation, nor management change, nor M&A, nor voting result. It is a general corporate announcement regarding office relocation, which does not match any specific filing category. Therefore it falls into the fallback category for miscellaneous regulatory announcements: RNS.
2026-03-26 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 95% confidence The document is a statutory notice filed with the Korean Financial Services Commission and Korea Exchange regarding the appointment, reappointment, dismissal, and mid-term resignation of outside directors. It details changes in board composition (outside directors), effective dates, and individual career information. This is clearly an announcement of changes in the company’s board of directors, matching the Board/Management Information category.
2026-03-26 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled “정기주주총회결과” (regular shareholders’ meeting results) and lists each agenda item with voting outcomes, vote counts, approval rates, and details of director and auditor elections. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-03-26 Korean
감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a regulatory filing titled '감사보고서 제출' (Submission of Audit Report) from CTC Bio. It provides a summary of financial data, audit opinions, and key financial metrics (assets, liabilities, profit/loss) for the current and previous fiscal years. While it contains financial data, it is a standard regulatory announcement (DART filing) notifying the market that the audit report has been submitted, rather than the full annual report document itself. Therefore, it fits the 'Report Publication Announcement' category. FY 2025
2026-03-18 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.